Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) Score
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- —0–3
- —4–6
- —7–9
- —10–100
The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) Score calculator is designed for bedside predicting both hematologic (grade 4) and nonhematologic (grade 3/4) toxicities based on patient characteristics and chemotherapy regimen in clinical practice. The resulting score directly guides clinician decision-making regarding adjusting systemic.
Clinical Guidelines & Evidence
Assesses the risk of severe chemotherapy toxicity in older cancer patients (≥70 years). Predicts both hematologic (grade 4) and nonhematologic (grade 3/4) toxicities based on patient characteristics and chemotherapy regimen.
Clinical Indication
The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) Score is indicated for bedside clinical practice to support Assesses the risk of severe chemotherapy toxicity in older cancer patients (≥70 years). Predicts both hematologic (grade 4) and nonhematologic (grade 3/4) toxicities based on patient characteristics and chemotherapy regimen.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.
Limitations & Contraindications
Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.
Clinical Pearls & Action Plan
Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival.
CRASH Score = Hematologic Subscore + Nonhematologic Subscore (chemotherapy risk counted only once in combined score)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| diastolic_bp | string | Yes | Diastolic blood pressure |
| iadl_score | string | Yes | Instrumental Activities of Daily Living (IADL) score |
| ldh | string | Yes | Lactate dehydrogenase (LDH) level(U/L) |
| chemo_risk_hematologic | string | Yes | Chemotherapy risk for hematologic toxicity |
| ecog_ps | string | Yes | ECOG Performance Status |
| mmse | string | Yes | Mini Mental State Examination (MMSE) score |
| mna | string | Yes | Mini Nutritional Assessment (MNA) score |
| chemo_risk_nonhematologic | string | Yes | Chemotherapy risk for nonhematologic toxicity |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–3 | — | Low risk |
| 4–6 | — | Low-intermediate risk |
| 7–9 | — | Intermediate-high risk |
| 10–100 | — | High risk |
Evidence-Based References (EBM)
- Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012 Jul 1;118(13):3377-86.
- Extermann M, Reich RR, Sehovic M. Chemotoxicity recalibration in the common terminology criteria for adverse events version 4.0 in older patients with cancer: Development of a training set. J Geriatr Oncol. 2013 Oct;4(4):353-8.
Related calculators
- Khorana Risk Score for Venous Thromboembolism in Cancer Patients
- Memorial Sloan-Kettering Cancer Center (MSKCC/Motzer) Score for Metastatic Renal Cell Carcinoma (RCC)
- Modified Glasgow Prognostic Score (mGPS) for Cancer Outcomes
- Fong Clinical Risk Score for Colorectal Cancer Recurrence
- Mekhail Extension of the Motzer Score